梁宏课题组
课题组成员
当前位置: 首页  课题组成员
刘延成 博士;教授;博士生导师


E-mail: ycliugxnu@aliyun.com

基本介绍

主要从事药物化学生物学领域的相关研究工作。研究方向为:①基于生物活性配体的抗肿瘤金属配合物及其作用机制研究;②新型金属基兽药的应用基础研究与开发工作。先后主持国家自然科学基金、广西自然科学基金、广西教育厅、广西医药产业人才小高地等项目10项,作为骨干成员参与国家自然科学基金、973计划前期研究专项等项目多项。已在Dalton Trans, Eur J Med Chem, Metallomics, J Inorg Biochem等期刊上发表SCI论文40余篇;获中国发明专利授权21项。荣获2017年度广西科学技术奖特别贡献奖1项(排名第七)、首届全区高校青年教师教学竞赛二等奖1项、指导学生获广西高校化学化工类论文及设计竞赛一等奖3项;已累计培养硕士12人,指导在读博士生1人、硕士生4人。

教育背景

2003.09-2007.07 南开大学,无机化学专业,博士

2000.09-2003.07 北京化工大学,化学工程与工艺专业,硕士

1996.09-2000.06 天津大学,生物化学工程专业,学士

工作经历

2018.11-2019.11 2018年度广西高校优秀教师出国留学资助项目资助,赴加拿大西蒙弗雷泽大学访学一年

2017.03-2018.09 广西师范大学,化学与药学学院副院长

2014.12-今 广西师范大学化学与药学学院,教授/博士生导师

2008.07-2014.11广西师范大学化学化工学院,副教授/硕士生导师

2008.09-2010.08 广西师范大学,在职博士后

2007.07-今 在广西师范大学化学与药学学院工作

Representative Publications

1. Ting Meng, Shang-Feng Tang, Qi-Pin Qin*, Yue-Lan Liang, Chen-Xuan Wu, Chen-Yu Wang, Hou-Tian Yan, Jia-Xin Dong and Yan-Cheng Liu*, Evaluation on the iodine-substituted effect of 8-hydroxyquinoline on its platinum(II) complex: Cytotoxicity, cell apoptosis and telomerase inhibition. MedChemCommum, 2016,7, 1802-1811.

2. Qi-Pin Qin, Yan-Cheng Liu*, Hai-Lu Wang, Jiao-Lan Qin, Feng-Jie Cheng, Shang-Feng Tang, Hong Liang*, Synthesis and antitumor mechanism of a copper(II) complex of anthracene-9-imidazoline hydrazone (9-AIH). Metallomics, 2015, 7, 1124-1136.

3. Yan-Cheng Liu, Zhen-Feng Chen*, Yan-Fang Shi, Ke-Bin Huang, Bo Geng, Hong Liang*. Oxoglaucine-lanthanide complexes: Synthesis, crystal structure and cytotoxicity. Anticancer Research, 2014, 34(1), 531-536.

4. Yu-Lan Li, Qi-Pin Qin, Yan-Cheng Liu*, Zhen-Feng Chen, Hong Liang. A platinum(II) complex of liriodenine from traditional Chinese medicine (TCM): Cell cycle arrest, cell apoptosis induction and telomerase inhibition activity via G-quadruplex DNA stabilization. J. Inorg. Biochem., 2014, 137, 12-21.

5. Yan-Cheng Liu, Jian-Hua Wei, Zhen-Feng Chen*, Mei Liu, Yun-Qiong Gu, Ke-Bin Huang, Zhu-Quan Li, Hong Liang*, The antitumor activity of zinc(II) and copper(II) complexes with 5,7-dihalo-substituted-8-quinolinoline. Eur. J. Med. Chem., 2013, 69, 554-563.

6. Yan-Cheng Liu, Zhen-Feng Chen*, Xiao-Yan Song, Yan Peng, Qi-Pin Qin and Hong Liang*, Synthesis, crystal structure, cytotoxicity and DNA interaction of 5,7-dibromo-8-quinolinolato-lanthanides. Eur. J. Med. Chem., 2013, 59, 168-175.

7. Zhen-Feng Chen*, Yan-Cheng Liu, Yan Peng, Xue Hong, Hong-Hong Wang, Min-Min Zhang, Hong Liang*. Synthesis, characterization, and in vitro antitumor properties of gold(III) compounds with the traditional Chinese medicine (TCM) active ingredient liriodenine. J. Biol. Inorg. Chem., 2012,17(2), 247-261.

8. Yan-Cheng Liu, Zhen-Feng Chen*, Li-Min Liu, Yan Peng, Xue Hong, Bin Yang, Hua-Gang Liu, Hong Liang*, Chris Orvig, Divalent later transition metal complexes of the traditional Chinese medicine (TCM) liriodenine: coordination chemistry, cytotoxicity and DNA binding studies. Dalton Trans., 2009, 48, 10813-10823.

9. Zhen-Feng Chen*, Yan-Cheng Liu, Li-Min Liu, Heng-Shan Wang, San-Hai Qin, Bo-Long Wang, He-Dong Bian, Bin Yang, Hua-Gang Liu*, Hong Liang*, Hoong-Kun Fun, Chris Orvig. Potential new inorganic antitumour agents from combining the anticancer traditional Chinese medicine (TCM) liriodenine with metal ions, and DNA binding studies. Dalton Trans., 2009, 2, 262-272.


点击次数: 131 更新时间: 2019-08-19